testing765 wrote: ... Is there a short information document available that explains the ADAPT protocol?
"...the ADAPT study, a Phase II clinical trial aimed at metastatic colon cancer patients that uses two drugs; capecitabine, a chemotherapy drug; and celecoxib, an arthritis medication more commonly known as Celebrex. Together, this combination is designed to wake up cancer stem cells that would otherwise hibernate during chemotherapy and kill them. So far, some 40% of Dr. Lin’s patients have achieved complete or near complete response from this drug combination..."
Reference: http://www.sccablog.org/2014/04/dr-ed-lin-gateway-cancer-researcher-of-the-year/
Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”
Users browsing this forum: No registered users and 299 guests